FindTrial
Sign In

Lidocaine patch 5%

DRUG9 trials

Sponsors

Endo Pharmaceuticals, University of Rochester, University of Campania Luigi Vanvitelli, University Hospital, Antwerp, Scilex Pharmaceuticals, Inc.

Conditions

Carpal Tunnel SyndromeChronic PainHealthyMultiple SclerosisMyofacial PainMyofascial Trigger Point PainNeuropathic PainPain, Postoperative

Phase 1

Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
CompletedNCT04149938
Scilex Pharmaceuticals, Inc.Healthy
Start: 2016-09-28End: 2016-10-27Updated: 2019-11-04
Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects
CompletedNCT04320173
Scilex Pharmaceuticals, Inc.Healthy
Start: 2017-02-14End: 2017-03-22Updated: 2020-03-24
Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects
CompletedNCT04319926
Scilex Pharmaceuticals, Inc.Healthy
Start: 2018-09-07End: 2018-09-09Updated: 2024-04-24

Phase 3

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome
TerminatedNCT00266214
Endo PharmaceuticalsCarpal Tunnel Syndrome
Start: 2005-11-30End: 2007-01-31Updated: 2011-06-14

Phase 4

Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
TerminatedNCT00414453
University of RochesterChronic Pain, Multiple Sclerosis, Neuropathic Pain
Start: 2007-01-31End: 2011-08-31Updated: 2015-07-17
Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment
TerminatedNCT03348735
University Hospital, AntwerpNeuropathic Pain
Start: 2018-12-03End: 2021-04-19Updated: 2021-04-28
Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department
WithdrawnNCT05151510
University of California, IrvineMyofacial Pain, Myofascial Trigger Point Pain
Start: 2021-11-01End: 2022-06-30Updated: 2026-02-13

Unknown Phase

Preventive Skin Analgesia With Lidocaine Patch 5% for Controlling Post-thoracotomy Pain
CompletedNCT02751619
University of Campania Luigi VanvitelliPain, Postoperative
Start: 2013-01-31End: 2015-12-31Updated: 2016-04-26
CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women
CompletedNCT05336825
Atlantic Health SystemVulvodynia
Start: 2019-04-01End: 2021-01-31Updated: 2022-04-20

Related Papers

Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study
Pain Research and Management2023-04-145 citations
Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects
Journal of Pain Research2021-02-017 citations
<p>A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects</p>
Journal of Pain Research2020-06-0111 citations